Indication

Angle-closure glaucoma

Angle-closure glaucoma is a form of optic neuropathy affecting the ocular visual system, characterized by mechanical obstruction of the anterior chamber drainage angle. Read more about Angle-closure glaucoma

53 drugs 42 manufacturers

Advertisement

Drugs that treat it

Common Angle-closure glaucoma therapies.

Showing 19–27 of 53 drugs

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
Major Pharamceuticals

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
GSK Consumer Healthcare

METHAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·OPEN ANGLE GLAUCOMA·+2
NORTHSTAR RX LL

METHAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·OPEN ANGLE GLAUCOMA·+2
BAUSCH & LOMB P

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
AVKARE

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
AVPAK
Filter & compare in the drug finder →Opens the drug finder with Angle-closure glaucoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Angle-closure glaucoma.

Angle-closure glaucoma is a form of optic neuropathy affecting the ocular visual system, characterized by mechanical obstruction of the anterior chamber drainage angle.

This condition primarily affects individuals with predisposing anatomical features, such as shallow anterior chambers, hyperopia, or advancing age, and can manifest as an acute ophthalmologic emergency or as an indolent chronic disease.

Pathophysiologically, apposition or adhesion between the peripheral iris and the trabecular meshwork—often precipitated by pupillary block—prevents aqueous humor outflow, leading to a marked rise in intraocular pressure, progressive retinal ganglion cell damage, and irreversible visual field loss.

Personalize your experience

Follow Angle-closure glaucoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it